Fact check
“The unique code would have made it easier for researchers and the public to track the regulatory histories of specific facilities.”
Reasoning
ProPublica articles describing the Clear Labels Act note that the required unique facility identification number (e.g., a DUNS number) on drug labels would allow researchers and the public to more easily trace drugs to the factories where they were made and to access FDA inspection reports, thereby making it easier to track regulatory histories of specific facilities.
On confidence: Multiple independent excerpts from the same primary source explicitly state that the unique code would have facilitated tracking of regulatory histories.
Important context
The claim refers specifically to the intended effect of the unique code provision in the legislation, not whether the provision was ultimately enacted.
Evidence
Supporting (3)
- Tier 1 — Primary sourceClear Labels Act Stripped of Critical Drug Safety Provisions — ProPublica
factories. That code would have made it easier for researchers and the public to track the regulatory histories of specific facilities. The requirements also were supposed to take effect as early as a year after the bill’s passage.…
- Tier 1 — Primary sourceClear Labels Act Stripped of Critical Drug Safety Provisions — ProPublica
provision made the law particularly strong, experts said: The label was supposed to include a unique code that the Food and Drug Administration uses to identify factories. That code would have made it easier for researchers and the public…
- Tier 1 — Primary sourceClear Labels Act Stripped of Critical Drug Safety Provisions — ProPublica
requirement to include a unique facility identification number on labels, called a DUNS number, which would have allowed the public to more easily trace a generic drug and its active ingredients to the factories where they were made. In…
Limitations
All evidence comes from a single news outlet (ProPublica). No additional independent sources were provided to corroborate the statement.
- Last verified:
- Sep 27, 2026, 4:24 AM CDT
- Pipeline:
- 2.1.0
- Claim type:
- Factual
Where this claim appeared
“A Clear Watering Down”: Drug Transparency Bill Stripped of Critical Provisions Ahead of Senate VoteProPublica · Naisha Roy